• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在篮子试验中进行贝叶斯信息借鉴时纳入历史信息以进一步提高检验效能。

Incorporating historic information to further improve power when conducting Bayesian information borrowing in basket trials.

作者信息

Daniells Libby, Mozgunov Pavel, Barnett Helen, Bedding Alun, Jaki Thomas

机构信息

STOR-i Centre for Doctoral Training, Lancaster University, Fylde College, Lancaster, Lancashire, LA1 4YF, United Kingdom.

MRC Biostatistics Unit, University of Cambridge, East Forvie Building, Robinson Way, Cambridge, Cambridgeshire, CB2 0SR, United Kingdom.

出版信息

Biostatistics. 2024 Dec 31;26(1). doi: 10.1093/biostatistics/kxaf016.

DOI:10.1093/biostatistics/kxaf016
PMID:40532037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12204204/
Abstract

In basket trials a single therapeutic treatment is tested on several patient populations simultaneously, each of which forming a basket, where patients across all baskets on the trial share a common genetic aberration. These trials allow testing of treatments on small groups of patients, however, limited basket sample sizes can result in inadequate precision and power of estimates. It is well known that Bayesian information borrowing models such as the exchangeability-nonexchangeability (EXNEX) model can be implemented to tackle such a problem, drawing on information from one basket when making inference in another. An alternative approach to improve power of estimates, is to incorporate any historical or external information available. This paper considers models that amalgamate both forms of information borrowing, allowing borrowing between baskets in the ongoing trial whilst also drawing on response data from historical sources, with the aim to further improve treatment effect estimates. We propose several Bayesian information borrowing approaches that incorporate historical information into the model. These methods are data-driven, updating the degree of borrowing based on the level of homogeneity between information sources. A thorough simulation study is presented to draw comparisons between the proposed approaches, whilst also comparing to the standard EXNEX model in which no historical information is utilized. The models are also applied to a real-life trial example to demonstrate their performance in practice. We show that the incorporation of historic data under the novel approaches can lead to a substantial improvement in precision and power of treatment effect estimates when such data is homogeneous to the responses in the ongoing trial. Under some approaches, this came alongside an inflation in type I error rate in cases of heterogeneity. However, the use of a power prior in the EXNEX model is shown to increase power and precision, whilst maintaining similar error rates to the standard EXNEX model.

摘要

在篮子试验中,单一治疗方法会同时在多个患者群体上进行测试,每个群体构成一个篮子,试验中所有篮子里的患者都有共同的基因畸变。这些试验允许对小群体患者进行治疗测试,然而,篮子样本量有限可能导致估计的精度和效能不足。众所周知,可以实施贝叶斯信息借用模型,如可交换性 - 不可交换性(EXNEX)模型来解决此类问题,即在对另一个篮子进行推断时借鉴一个篮子的信息。提高估计效能的另一种方法是纳入任何可用的历史或外部信息。本文考虑将两种信息借用形式结合的模型,既允许在正在进行的试验中的篮子之间借用信息,同时也借鉴历史来源的反应数据,目的是进一步改善治疗效果估计。我们提出了几种将历史信息纳入模型的贝叶斯信息借用方法。这些方法是数据驱动的,根据信息源之间的同质程度更新借用程度。本文进行了全面的模拟研究,以比较所提出的方法之间的差异,同时也与未使用历史信息的标准EXNEX模型进行比较。这些模型还应用于一个实际试验示例,以展示它们在实际中的表现。我们表明,当此类历史数据与正在进行的试验中的反应同质时,在新方法中纳入历史数据可导致治疗效果估计的精度和效能大幅提高。在某些方法下,在异质性情况下会伴随着I型错误率的上升。然而,在EXNEX模型中使用功效先验被证明可以提高效能和精度,同时保持与标准EXNEX模型相似的错误率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/b7b27d9e8384/kxaf016f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/cf65e8702c22/kxaf016f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/c3a09f305fd2/kxaf016f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/b7b27d9e8384/kxaf016f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/cf65e8702c22/kxaf016f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/c3a09f305fd2/kxaf016f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5cc/12204204/b7b27d9e8384/kxaf016f3.jpg

相似文献

1
Incorporating historic information to further improve power when conducting Bayesian information borrowing in basket trials.在篮子试验中进行贝叶斯信息借鉴时纳入历史信息以进一步提高检验效能。
Biostatistics. 2024 Dec 31;26(1). doi: 10.1093/biostatistics/kxaf016.
2
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.计算机和其他电子戒烟辅助手段的有效性和成本效益:系统评价和网络荟萃分析。
Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.

本文引用的文献

1
How to add baskets to an ongoing basket trial with information borrowing.如何在采用信息借用的情况下,为正在进行的篮子试验添加篮子。
Stat Methods Med Res. 2025 Apr;34(4):717-734. doi: 10.1177/09622802251316961. Epub 2025 Mar 20.
2
Dabrafenib and trametinib administration in patients with V600E/R or non-V600 mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.达拉非尼和曲美替尼用于治疗携带V600E/R或非V600突变的晚期实体瘤患者(BELIEVE,NCCH1901):一项多中心、开放标签的单臂II期试验。
EClinicalMedicine. 2024 Feb 2;69:102447. doi: 10.1016/j.eclinm.2024.102447. eCollection 2024 Mar.
3
Bayesian Methods for Information Borrowing in Basket Trials: An Overview.
篮子试验中信息借用的贝叶斯方法:综述
Cancers (Basel). 2024 Jan 5;16(2):251. doi: 10.3390/cancers16020251.
4
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.贝叶斯信息借用方法在篮子试验中的比较及一种改进的可交换性-不可交换性方法的新提议。
Stat Med. 2023 Oct 30;42(24):4392-4417. doi: 10.1002/sim.9867. Epub 2023 Aug 23.
5
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.达拉非尼联合曲美替尼治疗 BRAFV600E 突变罕见癌症:Ⅱ期 ROAR 试验。
Nat Med. 2023 May;29(5):1103-1112. doi: 10.1038/s41591-023-02321-8. Epub 2023 Apr 14.
6
Bayesian local exchangeability design for phase II basket trials.贝叶斯局部交换设计在 II 期篮子试验中的应用。
Stat Med. 2022 Sep 30;41(22):4367-4384. doi: 10.1002/sim.9514. Epub 2022 Jul 1.
7
Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials.最优贝叶斯层级模型加速组织不可知药物和篮子试验的发展。
Contemp Clin Trials. 2021 Aug;107:106460. doi: 10.1016/j.cct.2021.106460. Epub 2021 Jun 15.
8
A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.一种新的等效概率加权幂先验方法,用于自适应临床试验设计中使用历史对照数据:与标准方法的比较。
Pharm Stat. 2021 May;20(3):462-484. doi: 10.1002/pst.2088. Epub 2021 Jan 20.
9
Statistical design considerations for trials that study multiple indications.针对多适应症研究的试验的统计设计考虑因素。
Stat Methods Med Res. 2021 Mar;30(3):785-798. doi: 10.1177/0962280220975187. Epub 2020 Dec 2.
10
Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.基于分布差异的篮子试验中患者亚组间信息的借用。
Biostatistics. 2022 Jan 13;23(1):120-135. doi: 10.1093/biostatistics/kxaa019.